Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers

Details for Australian Patent Application No. 2009286594 (hide)

Owner Universite De Franche Comte Diaclone ESF Bourgogne Franche Comte

Inventors Borg, Christophe; Wijdenes, John; Grand Clement, Camille

Agent Fisher Adams Kelly

Pub. Number AU-A-2009286594

PCT Pub. Number WO2010/023382

Priority 0804725 27.08.08 FR

Filing date 26 August 2009

Wipo publication date 4 March 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/023382 Priority application(s): WO2010/023382

16 August 2012 Alteration of Name

  The name of the applicant has been altered to Universite De Franche Comte; Diaclone; Etablissement Francais du Sang 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009286596-Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy

2009286591-Mechanized portable electric tool with two shafts